Shiro Murata Selected Research

Shiro Murata Research Topics

Disease

14	Disease Progression 09/2023 - 05/2012
13	Neoplasms (Cancer) 06/2023 - 01/2014
11	Persistent Infection 09/2023 - 09/2011
11	Deltaretrovirus Infections (BLV Infection) 01/2023 - 09/2011
9	Infections 01/2020 - 05/2012
8	Marek Disease (Marek's Disease) 01/2024 - 09/2007
7	Melanoma (Melanoma, Malignant) 06/2023 - 01/2016
6	Paratuberculosis (Johne's Disease) 10/2022 - 01/2016
2	Carcinogenesis 01/2024 - 11/2021
2	Cattle Diseases (Bovine Diseases) 01/2022 - 07/2014
2	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2019
2	Chronic Disease (Chronic Diseases) 10/2019 - 01/2017
1	Listeriosis (Listeria Infection) 07/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2023
1	Diarrhea 01/2023
1	Adenocarcinoma 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Horse Diseases (Horse Disease) 01/2020
1	Inflammation (Inflammations) 02/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Anaplasmosis 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Lymphocytosis 03/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Lymphoma (Lymphomas) 08/2014
1	Coinfection 10/2013
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 06/2013
1	Babesiosis (Piroplasmosis) 10/2012
1	Disease Resistance 08/2012

Drug/Important Bio-Agent (IBA)

13	LigandsIBA 01/2023 - 09/2011
11	B7-H1 AntigenIBA 06/2023 - 09/2011
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2011
6	AntibodiesIBA 01/2023 - 01/2016
6	CytokinesIBA 01/2023 - 08/2012
5	Monoclonal AntibodiesIBA 07/2023 - 01/2017
5	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2016
5	AntigensIBA 10/2022 - 01/2014
5	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2018
4	Immune Checkpoint ProteinsIBA 09/2023 - 01/2017
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020 - 01/2018
3	Messenger RNA (mRNA)IBA 02/2015 - 05/2012
2	MucinsIBA 01/2023 - 05/2012
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 02/2019
2	ProstaglandinsIBA 10/2022 - 01/2019
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2020
2	VaccinesIBA 12/2020 - 06/2016
2	Blocking AntibodiesIBA 01/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 05/2014 - 09/2007
1	Protein Isoforms (Isoforms)IBA 01/2024
1	Complementary DNA (cDNA)IBA 07/2023
1	Viral VaccinesIBA 03/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	InterferonsIBA 01/2023
1	CTLA-4 AntigenIBA 10/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Interleukin-2 (IL2)IBA 12/2021
1	Oncogene Proteins (Oncogene Protein)IBA 11/2021
1	Protein SIBA 11/2021
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	vesatolimodIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019
1	Meloxicam (Mobic)FDA LinkGeneric 01/2019
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2019
1	Tuberculin (PPD)IBA 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	PerforinIBA 03/2016
1	Immunoglobulin M (IgM)IBA 08/2014
1	Oligonucleotide ProbesIBA 10/2013
1	Proline (L-Proline)FDA Link 06/2013
1	Histocompatibility Antigens Class IIIBA 01/2013
1	MineralsIBA 10/2012
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2012

Therapy/Procedure

11	Therapeutics 06/2023 - 07/2013
9	Immunotherapy 01/2023 - 09/2011
1	Radiotherapy 06/2023
1	Transjugular Intrahepatic Portasystemic Shunt 09/2007